Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients

Gonzalo Laje; Níall Lally; Daniel Mathews; Nancy Brutsche; Anat Chemerinski; Nirmala Akula; Benjamin Kelmendi; Arthur Simen; Francis J. McMahon; Gerard Sanacora; Carlos Zarate

doi:10.1016/j.biopsych.2012.05.031

Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients

Gonzalo Laje, Níall Lally, Daniel Mathews, Nancy Brutsche, Anat Chemerinski, Nirmala Akula, Benjamin Kelmendi, Arthur Simen, Francis J. McMahon, Gerard Sanacora, Carlos Zarate

Research output: Contribution to journal › Letter › peer-review

128 Scopus citations

Original language	English (US)
Pages (from-to)	e27-e28
Journal	Biological psychiatry
Volume	72
Issue number	11
DOIs	https://doi.org/10.1016/j.biopsych.2012.05.031
State	Published - Dec 1 2012
Externally published	Yes

ASJC Scopus subject areas

Biological Psychiatry

Access to Document

10.1016/j.biopsych.2012.05.031

Cite this

@article{217645eb53854074bcddd0ffd60a1ba4,

title = "Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients",

author = "Gonzalo Laje and N{\'i}all Lally and Daniel Mathews and Nancy Brutsche and Anat Chemerinski and Nirmala Akula and Benjamin Kelmendi and Arthur Simen and McMahon, {Francis J.} and Gerard Sanacora and Carlos Zarate",

note = "Funding Information: This study was funded in part by the Intramural Research Program of the National Institute of Mental Health (NIMH), National Institutes of Health , by Grant No. K99MH085098 to Gonzalo Laje; by a National Alliance for Research on Schizophrenia and Depression Independent Investigator Award to Francis McMahon and Carlos Zarate Jr.; and by the Brain and Behavior Award for Bipolar Disorder Mood Research. The content of this publication does not necessarily reflect the views or policies of the U.S. Department of Health and Human Services nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. ",

year = "2012",

month = dec,

day = "1",

doi = "10.1016/j.biopsych.2012.05.031",

language = "English (US)",

volume = "72",

pages = "e27--e28",

journal = "Biological Psychiatry",

issn = "0006-3223",

publisher = "Elsevier USA",

number = "11",

}

TY - JOUR

T1 - Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients

AU - Laje, Gonzalo

AU - Lally, Níall

AU - Mathews, Daniel

AU - Brutsche, Nancy

AU - Chemerinski, Anat

AU - Akula, Nirmala

AU - Kelmendi, Benjamin

AU - Simen, Arthur

AU - McMahon, Francis J.

AU - Sanacora, Gerard

AU - Zarate, Carlos

N1 - Funding Information: This study was funded in part by the Intramural Research Program of the National Institute of Mental Health (NIMH), National Institutes of Health , by Grant No. K99MH085098 to Gonzalo Laje; by a National Alliance for Research on Schizophrenia and Depression Independent Investigator Award to Francis McMahon and Carlos Zarate Jr.; and by the Brain and Behavior Award for Bipolar Disorder Mood Research. The content of this publication does not necessarily reflect the views or policies of the U.S. Department of Health and Human Services nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.

PY - 2012/12/1

Y1 - 2012/12/1

UR - http://www.scopus.com/inward/record.url?scp=84868208976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868208976&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2012.05.031

DO - 10.1016/j.biopsych.2012.05.031

M3 - Letter

C2 - 22771240

AN - SCOPUS:84868208976

VL - 72

SP - e27-e28

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 11

ER -

Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this